Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Pigmented Lesion Assay | Metadata changed |
| May 8, 2026 | CMS / Medicare | Nonvascular Extremity Ultrasound | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Biomarker Testing (Prior to Initial Biopsy) for Prostate Cancer Diagnosis | Metadata changed |
| May 8, 2026 | CMS / Medicare | Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015, or later | Metadata changed |
| May 8, 2026 | CMS / Medicare | BDX-XL2 | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Facet Joint Interventions for Pain Management (DL38841) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cosmetic and Reconstructive Surgery | Metadata changed |
| May 8, 2026 | CMS / Medicare | Wound Care | Metadata changed |
| May 8, 2026 | CMS / Medicare | Antibacterial Drugs | Metadata changed |
| May 8, 2026 | CMS / Medicare | Nerve Blocks and Electrostimulation for Peripheral Neuropathy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Acute Myelogenous Leukemia (AML) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Micro-Invasive Glaucoma Surgery (MIGS) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Human Tumor Stem Cell Drug Sensitivity Assays | Metadata changed |
| May 8, 2026 | CMS / Medicare | Pain Management - Injection of tendon sheaths, ligaments, bursa, and ganglion cysts | Metadata changed |
| May 8, 2026 | CMS / Medicare | Cold Therapy - Policy Article | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Special Histochemical Stains and Immunohistochemical Stains, L36353 | Metadata changed |
| May 8, 2026 | CMS / Medicare | Blood Platelet Transfusions | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Transcatheter Tricuspid Valve Replacement (TTVR) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Nerve Conduction Studies and Electromyography | Metadata changed |
| May 8, 2026 | CMS / Medicare | Psychiatric Diagnostic Evaluation and Psychotherapy Services | Metadata changed |
| May 8, 2026 | CMS / Medicare | Fabric Wrapping of Abdominal Aneurysms | Metadata changed |
| May 8, 2026 | CMS / Medicare | Respiratory Assist Devices - Policy Article | Metadata changed |
| May 8, 2026 | CMS / Medicare | Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Intervertebral Disc Repair | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Glucose Monitors â DL33822 | Metadata changed |
| May 8, 2026 | CMS / Medicare | Sensory Nerve Conduction Threshold Tests (sNCTs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs) | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Transurethral Waterjet Ablation of the Prostate | Metadata changed |
| May 8, 2026 | CMS / Medicare | Controlled Substance Monitoring and Drugs of Abuse Testing | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: DecisionDx-Melanoma | Metadata changed |
| May 8, 2026 | CMS / Medicare | Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities | Metadata changed |
| May 8, 2026 | CMS / Medicare | Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Metadata changed |
| May 8, 2026 | CMS / Medicare | Off-Label Use of Intravenous Immune Globulin (IVIG) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Dialysis Access Maintenance | Metadata changed |
| May 8, 2026 | CMS / Medicare | FDG PET for Esophageal Cancer (Replaced with Section 220.6.17) - RETIRED | Metadata changed |
| May 8, 2026 | CMS / Medicare | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin and Non-Hodgkin Lymphoma with B-cell or T-cell Origin | Metadata changed |
| May 8, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Metadata changed |
| May 8, 2026 | CMS / Medicare | Respiratory Care | Metadata changed |
| May 8, 2026 | CMS / Medicare | Debridement Services | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: Proton Beam Therapy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Assessing Patient's Suitability for Electrical Nerve Stimulation Therapy | Metadata changed |
| May 8, 2026 | CMS / Medicare | Urine Culture, Bacterial | Metadata changed |
| May 8, 2026 | CMS / Medicare | Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring) | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Metadata changed |
| May 8, 2026 | CMS / Medicare | Pelvic Floor Dysfunction: Anorectal Manometry and EMG | Metadata changed |
| May 8, 2026 | CMS / Medicare | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Metadata changed |